Altogether, these findings support the hypothesis that hypertension may influence the neuroinflammatory pathological cycle of astrocyte activation, subsequently inducing endothelial dysfunction and further aggravating tau pathology in AD. The gene discussed is MAPT; the disease is Alzheimer disease.